Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
138.85
Change Change %
1.50 1.09%

Updated:25 Feb, 2020, 09:44 AM IST

BSE
138.80
Change Change %
1.45 1.06%

Updated:25 Feb, 2020, 09:49 AM IST

Bliss GVS Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 86.84 94.91 -8.50%
Adjustments for Expenses & Provisions 0.77 28.12 -97.28%
Adjustments for Liabilities & Assets -29.06 -47.37 38.65%
Cash Flow from operating activities 22.67 38.48 -41.09%
Cash Flow from investing activities 22.27 -29.34 175.89%
Cash Flow from financing activities -21.91 -14.77 -48.34%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents 23.03 -5.63 509.27%
Opening Cash & Cash Equivalents 7.33 12.95 -43.44%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 30.36 7.33 314.39%
Top